Advertisement
Letter to the Editor| Volume 5, ISSUE 4, 100865, April 2023

Download started.

Ok

Prediction of hypertensive disorders of pregnancy using metabolomics: there is a long way to go

Published:January 20, 2023DOI:https://doi.org/10.1016/j.ajogmf.2023.100865
      Hypertensive disorders of pregnancy (HDP) are the most common medical complication of pregnancy, affecting approximately 10% of pregnancies.
      Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.
      They are still a leading cause of maternal and perinatal mortality worldwide. As a consequence, antenatal care is devoted in large part to their detection and prediction. The risk factors for HDP are related to clinical epidemiologic, hemodynamic, and basic biochemical factors. For example, combining clinical maternal risk markers, placental growth factor, and uterine artery pulsatility index in the first trimester of pregnancy has sensitivities of 75% for preterm preeclampsia and 47% for term preeclampsia, whereas the use of clinical risk markers alone has sensitivities of 34% for preterm preeclampsia and 39% for term preeclampsia.
      • Magee LA
      • Smith GN
      • Bloch C
      • et al.
      Guideline No. 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology MFM
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.
        Am J Obstet Gynecol. 2000; 183: S1-22
        • Magee LA
        • Smith GN
        • Bloch C
        • et al.
        Guideline No. 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management.
        J Obstet Gynaecol Can. 2022; 44 (e1): 547-571
        • Varghese B
        • Jala A
        • Meka S
        • et al.
        Integrated metabolomics and machine learning approach to predict hypertensive disorders of pregnancy.
        Am J Obstet Gynecol MFM. 2022; 5100829
        • Mayrink J
        • Leite DF
        • Nobrega GM
        • Costa ML
        • Cecatti JG.
        Prediction of pregnancy-related hypertensive disorders using metabolomics: a systematic review.
        BMJ Open. 2022; 12e054697